SG11201908596WA - Mmlv reverse transcriptase variants - Google Patents
Mmlv reverse transcriptase variantsInfo
- Publication number
- SG11201908596WA SG11201908596WA SG11201908596WA SG11201908596WA SG 11201908596W A SG11201908596W A SG 11201908596WA SG 11201908596W A SG11201908596W A SG 11201908596WA SG 11201908596W A SG11201908596W A SG 11201908596WA
- Authority
- SG
- Singapore
- Prior art keywords
- koll
- pleasanton
- suite
- california
- parkway
- Prior art date
Links
- 102100034343 Integrase Human genes 0.000 title abstract 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 title abstract 2
- 238000010839 reverse transcription Methods 0.000 abstract 4
- 102000004190 Enzymes Human genes 0.000 abstract 3
- 108090000790 Enzymes Proteins 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 241000713869 Moloney murine leukemia virus Species 0.000 abstract 1
- 239000013592 cell lysate Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 108020004999 messenger RNA Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07049—RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
1 • 4 N QC O O r•i 00 O 1-1 r•i O (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 01 November 2018 (01.11.2018) WIPO I PCT ~ill IIIIIIIIIImillIVIIIIIIIHo o olo Iniolioo Imo oimIE (10) International Publication Number WO 2018/200867 Al (51) International Patent Classification: C12N 9/12 (2006.01) Cl 2N 15/33 (2006.01) C12N 9/22 (2006.01) (21) International Application Number: PCT/US2018/029641 (22) International Filing Date: 26 April 2018 (26.04.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/490,492 26 April 2017 (26.04.2017) US (71) Applicant: 10X GENOMICS, INC. [US/US]; 7068 Koll Center Parkway, Suite 401, Pleasanton, California 94566 (US). (72) Inventors: LEE, Josephine; 7068 Koll Center Parkway, Suite 401, Pleasanton, California 94566 (US). MARRS, Sa- muel; 7068 Koll Center Parkway, Suite 401, Pleasanton, California 94566 (US). MCDERMOTT, Geoffrey; 7068 Koll Center Parkway, Suite 401, Pleasanton, California 94566 (US). MESCHI, Francesca; 7068 Koll Center Park- way, Suite 401, Pleasanton, California 94566 (US). MON- TESCLAROS, Luz; 7068 Koll Center Parkway, Suite 401, Pleasanton, California 94556 (US). PFEIFFER, Kather- ine; 7068 Koll Center Parkway, Suite 401, Pleasanton, California 94566 (US). SHUGA, Joseph Francis; 7068 Koll Center Parkway, Suite 401, Pleasanton, California 94566 (US). TERRY, Jessica Michele; 7068 Koll Cen- ter Parkway, Suite 401, Pleasanton, California 94556 (US). ZIRALDO, Solongo B.; 7068 Koll Center Parkway, Suite 401, Pleasanton, California 94566 (US). (74) Agent: SCHULTZ, Jason; WILSON SONSINI GOODRICH & ROSATI, 650 Page Mill Road, Palo Alto, US 94304 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (54) Title: MMLV REVERSE TRANSCRIPTASE VARIANTS 100 104 106 FIG. 1 (57) : Disclosed herein, are compositions, methods, and kits comprising engineered reverse transcription enzymes that ex- hibit several desired properties such as thermal stability, processive reverse transcription, non-templated base addition, and template switching ability. The engineered reverse transcription enzymes described herein demonstrate unexpectedly higher resistance to cell lysate inhibition, greater ability to capture full-length mRNA transcripts, and demonstrate improved results in small reaction volumes as compared to other engineered reverse transcription enzymes. [Continued on next page] WO 2018/200867 Al MIDEDIMOMOIDEIRDERI001010111MIIIMERVOIMIE DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: with international search report (Art. 21(3)) before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h))
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762490492P | 2017-04-26 | 2017-04-26 | |
PCT/US2018/029641 WO2018200867A1 (en) | 2017-04-26 | 2018-04-26 | Mmlv reverse transcriptase variants |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201908596WA true SG11201908596WA (en) | 2019-11-28 |
Family
ID=63918723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201908596W SG11201908596WA (en) | 2017-04-26 | 2018-04-26 | Mmlv reverse transcriptase variants |
Country Status (4)
Country | Link |
---|---|
EP (2) | EP4375376A3 (en) |
CN (1) | CN110637084A (en) |
SG (1) | SG11201908596WA (en) |
WO (1) | WO2018200867A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK3752634T3 (en) * | 2018-02-13 | 2022-10-24 | Illumina Inc | DNA Sequencing Using Hydrogel Beads / DNA sequencing using hydrogel beads |
CN112442493A (en) * | 2019-08-30 | 2021-03-05 | 广东菲鹏生物有限公司 | Thermostable reverse transcriptase |
WO2021119320A2 (en) | 2019-12-11 | 2021-06-17 | 10X Genomics, Inc. | Reverse transcriptase variants |
CN111647576B (en) * | 2020-06-24 | 2021-02-09 | 南京诺唯赞生物科技股份有限公司 | Thermostable reverse transcriptase mutant and application thereof |
CN112011596A (en) * | 2020-09-11 | 2020-12-01 | 深圳华大因源医药科技有限公司 | Method, solution and kit for simultaneously detecting multiple microbial genomes |
WO2022232571A1 (en) * | 2021-04-30 | 2022-11-03 | 10X Genomics, Inc. | Fusion rt variants for improved performance |
CN113355303B (en) * | 2021-06-07 | 2023-06-16 | 中元汇吉生物技术股份有限公司 | M-MLV reverse transcriptase mutant and application thereof |
WO2022265965A1 (en) * | 2021-06-14 | 2022-12-22 | 10X Genomics, Inc. | Reverse transcriptase variants for improved performance |
CN113817707B (en) * | 2021-11-23 | 2022-02-22 | 中国医学科学院北京协和医院 | Mutant recombinant reverse transcriptase and preparation method and application thereof |
WO2023114473A2 (en) * | 2021-12-16 | 2023-06-22 | 10X Genomics, Inc. | Recombinant reverse transcriptase variants for improved performance |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7516694A (en) | 1993-07-30 | 1995-02-28 | Affymax Technologies N.V. | Biotinylation of proteins |
JP2004511211A (en) * | 2000-05-26 | 2004-04-15 | インヴィトロジェン コーポレーション | Thermostable reverse transcriptase and its use |
WO2007022045A2 (en) * | 2005-08-10 | 2007-02-22 | Stratagene California | Mutant reverse transcriptase and methods of use |
EP2077912B1 (en) | 2006-08-07 | 2019-03-27 | The President and Fellows of Harvard College | Fluorocarbon emulsion stabilizing surfactants |
GB0806562D0 (en) * | 2008-04-10 | 2008-05-14 | Fermentas Uab | Production of nucleic acid |
WO2012149042A2 (en) * | 2011-04-25 | 2012-11-01 | Bio-Rad Laboratories, Inc. | Methods and compositions for nucleic acid analysis |
CN114891871A (en) | 2012-08-14 | 2022-08-12 | 10X基因组学有限公司 | Microcapsule compositions and methods |
US20140378345A1 (en) | 2012-08-14 | 2014-12-25 | 10X Technologies, Inc. | Compositions and methods for sample processing |
EP3097190A2 (en) * | 2014-01-22 | 2016-11-30 | Life Technologies Corporation | Novel reverse transcriptases for use in high temperature nucleic acid synthesis |
JP6726659B2 (en) | 2014-04-10 | 2020-07-22 | 10エックス ジェノミクス, インコーポレイテッド | Fluidic devices, systems and methods for encapsulating and partitioning reagents and their applications |
KR20230070325A (en) | 2014-06-26 | 2023-05-22 | 10엑스 제노믹스, 인크. | Methods of analyzing nucleic acids from individual cells or cell populations |
CN106536756A (en) | 2014-06-26 | 2017-03-22 | 10X基因组学有限公司 | Analysis of nucleic acid sequences |
WO2015200871A1 (en) | 2014-06-26 | 2015-12-30 | 10X Genomics, Inc. | Methods and compositions for sample analysis |
EP4105337A1 (en) * | 2014-09-09 | 2022-12-21 | The Broad Institute, Inc. | A droplet-based method and apparatus for composite single-cell nucleic acid analysis |
US9580698B1 (en) * | 2016-09-23 | 2017-02-28 | New England Biolabs, Inc. | Mutant reverse transcriptase |
-
2018
- 2018-04-26 SG SG11201908596W patent/SG11201908596WA/en unknown
- 2018-04-26 EP EP24167618.8A patent/EP4375376A3/en active Pending
- 2018-04-26 EP EP18791768.7A patent/EP3592847B1/en active Active
- 2018-04-26 CN CN201880032804.6A patent/CN110637084A/en active Pending
- 2018-04-26 WO PCT/US2018/029641 patent/WO2018200867A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3592847B1 (en) | 2024-06-05 |
EP4375376A3 (en) | 2024-08-14 |
CN110637084A (en) | 2019-12-31 |
WO2018200867A1 (en) | 2018-11-01 |
EP3592847A4 (en) | 2021-05-05 |
EP3592847C0 (en) | 2024-06-05 |
EP3592847A1 (en) | 2020-01-15 |
EP4375376A2 (en) | 2024-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201908596WA (en) | Mmlv reverse transcriptase variants | |
SG11201901531TA (en) | Regulation of gene expression using engineered nucleases | |
SG11201804836RA (en) | Treatment of fibrosis | |
SG11201901371XA (en) | Methods for the detection of genomic copy changes in dna samples | |
SG11201907566TA (en) | Methods and compositions for labeling cells | |
SG11201810179RA (en) | Novel crispr enzymes and systems | |
SG11201810003UA (en) | Using programmable dna binding proteins to enhance targeted genome modification | |
SG11201803983UA (en) | Transformable tagging compositions, methods, and processes incorporating same | |
SG11201808751SA (en) | T cell receptors | |
SG11201807252QA (en) | Anti-lag-3 antibodies | |
SG11201901563UA (en) | De novo synthesized nucleic acid libraries | |
SG11201809344QA (en) | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde | |
SG11201908787WA (en) | Novel bispecific antigen binding molecules capable of specific binding to cd40 and to fap | |
SG11201903456WA (en) | Piperidine derivatives as inhibitors of ubiquitin specific protease 7 | |
SG11201407417VA (en) | Encoding and reconstruction of residual data based on support information | |
SG11201810210UA (en) | Engineered botulinum neurotoxins | |
SG11201806845VA (en) | Moisturizing compositions and uses thereof | |
SG11201900746RA (en) | Engineered antibodies and other fc-domain containing molecules with enhanced agonism and effector functions | |
SG11201909957TA (en) | Engineered ligase variants | |
SG11201900753VA (en) | A method of isolating mesenchymal stem cells from umbilical cord amniotic membrane using a cell culture medium | |
SG11201407037UA (en) | Catechol o-methyltransferase activity inhibiting compounds | |
SG11201804916PA (en) | Three-dimensional polymer networks with channels situated therein | |
SG11201907420VA (en) | Inhibition of smarca2 for treatment of cancer | |
SG11201804712PA (en) | Biofuel | |
SG11201909419XA (en) | Hydrogel for cell culture and biomedical applications |